Non-eosinophilic corticosteroid unresponsive asthma.

Non-eosinophilic corticosteroid unresponsive asthma.

Bibliographic Details
Main Authors:	Pavord, I, Brightling, C, Woltmann, G, Wardlaw, A
Format:	Journal article
Language:	English
Published:	1999

Similar Items

Eosinophils in asthma and other allergic diseases.
by: Wardlaw, A, et al.
Published: (2000)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
by: Berry, M, et al.
Published: (2007)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
by: Brightling, C, et al.
Published: (1999)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
by: Green, R, et al.
Published: (2002)

The significance of eosinophilic airway inflammation in asthma
by: Pavord, I, et al.
Published: (2002)

Eosinophils in asthma and airway hyperresponsiveness.
by: Brightling, C, et al.
Published: (2004)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
by: Brightling, C, et al.
Published: (2003)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
by: Brightling, C, et al.
Published: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
by: Brightling, C, et al.
Published: (2000)

A comparison of the validity of different diagnostic tests in adults with asthma.
by: Hunter, C, et al.
Published: (2002)

Biomarkers predicting response to corticosteroid therapy in asthma.
by: Brightling, C, et al.
Published: (2005)

Mepolizumab in refractory eosinophilic asthma.
by: Pavord, I, et al.
Published: (2010)

New insights into the relationship between airway inflammation and asthma.
by: Wardlaw, A, et al.
Published: (2002)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
by: Kulkarni, N, et al.
Published: (2010)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
by: Berry, M, et al.
Published: (2005)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
by: Green, R, et al.
Published: (2002)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
by: Brightling, C, et al.
Published: (2002)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
by: Siddiqui, S, et al.
Published: (2007)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2017)

Non-eosinophilic asthma and the innate immune response.
by: Pavord, I
Published: (2007)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
by: Mistry Vijay, et al.
Published: (2009-07-01)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
by: Berry, M, et al.
Published: (2004)

Eosinophilic bronchitis is an important cause of chronic cough.
by: Brightling, C, et al.
Published: (1999)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
by: Bilocca, D, et al.
Published: (2017)

TNF-alpha in asthma.
by: Berry, M, et al.
Published: (2007)

Inhaled corticosteroids in COPD.
by: Brightling, C, et al.
Published: (1999)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
by: Brightling, C, et al.
Published: (2000)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
by: Brightling, C, et al.
Published: (2004)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
by: Haldar, P, et al.
Published: (2014)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma
by: Hynes, G, et al.
Published: (2018)

New insights into the role of the mast cell in asthma.
by: Brightling, C, et al.
Published: (2003)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
by: Woltmann, G, et al.
Published: (1999)

Management of asthma in adults: current therapy and future directions.
by: Green, R, et al.
Published: (2003)

Eosinophilic bronchitis - what is it and why is it important?
by: Brightling, C, et al.
Published: (2000)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
by: Yancey, S, et al.
Published: (2016)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
by: Saha, S, et al.
Published: (2006)

Induced sputum eicosanoid concentrations in asthma.
by: Pavord, I, et al.
Published: (1999)

Eosinophilic bronchitis: an important cause of prolonged cough.
by: Brightling, C, et al.
Published: (2000)